Edition:
United States

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

1.43USD
4:00pm EDT
Change (% chg)

$-0.01 (-0.69%)
Prev Close
$1.44
Open
$1.44
Day's High
$1.45
Day's Low
$1.41
Volume
21,804
Avg. Vol
80,746
52-wk High
$11.35
52-wk Low
$1.41

Chart for

About

Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $50.77
Shares Outstanding(Mil.): 33.18
Dividend: --
Yield (%): --

Financials

  CRIS.OQ Industry Sector
P/E (TTM): -- 99.04 30.20
EPS (TTM): -1.36 -- --
ROI: -97.64 3.31 12.77
ROE: -525.11 2.31 14.92

BRIEF-Curis Files For Mixed Shelf Of Upto $200 Mln

* CURIS INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: (https://bit.ly/2rkihf5) Further company coverage:

May 03 2018

BRIEF-Curis Reports Q1 Loss Per Share $0.07

* Q1 EARNINGS PER SHARE VIEW $-0.09 -- THOMSON REUTERS I/B/E/S

May 03 2018

BRIEF-Curis Q4 Loss Per Share $0.05

* CURIS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS

Mar 08 2018

Earnings vs. Estimates